22 April 2024 - Acadia Pharmaceuticals today announced that Health Canada has accepted its new drug submission for trofinetide for the ...
3 April 2024 - AB Science today announced that Health Canada has granted eligibility for reconsideration request for masitinib in ...
1 April 2024 - Exa-cel is the first CRISPR-based gene-edited therapy to be submitted for Health Canada review. ...
19 March 2024 - Health Canada regulatory decision on tofersen new drug submission expected in early 2025. ...
9 May 2023 - AB Science today announces that Health Canada has issued a screening acceptance letter for ...
26 February 2024 - Submission supported by positive results of a Phase 3 study showing immune response and tolerability in adults ...
30 January 2024 - GSK announces that Heath Canada has accepted into review the new drug submission for momelotinib, a potential ...
10 January 2024 - Application is supported by data from the pivotal Phase 2b/3 studies evaluating safety and efficacy of long-acting ...
8 January 2024 - Supplement to a new drug submission supported by positive Phase 2 and Phase 3 pivotal trial ...
27 December 2023 - Celltrion said Wednesday that it has completed the submission of its marketing authorisation application for its ...
26 December 2023 - The anticipated timeline for approval in Canada is approximately 12 months depending on review cycles and ...
30 November 2023 - Duchesnay has recently filed a new drug submission to Health Canada for its segesterone acetate/ethinyl estradiol slow ...
29 August 2023 - Valneva today announced that Health Canada has completed screening validation of the Company’s regulatory application for ...
29 June 2023 - Health Canada submission follows international recommendations to develop monovalent XBB.1.5 COVID-19 vaccines. ...
12 June 2023 - One-third of the new active substances approved in the United States and Europe between 2016 and ...